Life Sciences Investment Banking
An experienced team in a vibrant sector.
Raymond James Life Sciences practice provides comprehensive advisory and financing capabilities to innovative businesses in the biotechnology, specialty pharmaceutical and generic pharmaceutical sectors. Companies within the biopharma industry continue to face the disruptive forces that require them to tailor their strategies in the continually evolving business environment. Our team provides our clients with solutions based on our deep relationships with company management teams as well as venture, private equity and public market investors.
Life Sciences Subsector Expertise
- Specialty Pharmaceuticals
Senior Banking Team
Transaction history may include a transaction completed by a Raymond James banker while at a former firm.
Investment Banking | April 28, 2022
60% of GP-leds price at par or better, buyers expect a decline of 10% or more in valuations in the coming quarterRead More about 60% of GP-leds price at par or better, buyers expect a decline of 10% or more in valuations in the coming quarter
Global Equities | March 23, 2022
Raymond James hires consumer sector analyst Rick B. PatelRead More about Raymond James hires consumer sector analyst Rick B. Patel
Investment Banking | March 21, 2022